title: Hand-foot syndrome with docetaxel: a five-case series.
authors.affiliation: Department of Internal Medicine, American University of Beirut, Beirut, Lebanon. bellanotchi@hotmail.com
authors.forename: Mirna H
authors.initials: MH
authors.lastname: Farhat
authors.forename: Nagi S
authors.initials: NS
authors.lastname: El-Saghir
authors.forename: Ali I
authors.initials: AI
authors.lastname: Shamseddine
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D013577:Syndrome; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel
references.citation: Eur J Haematol. 2002 Nov-Dec;69(5-6):315-7
references.pmid: 12460237
references.citation: Am J Clin Dermatol. 2000 Jul-Aug;1(4):225-34
references.pmid: 11702367
references.citation: Ann Oncol. 2001 Dec;12(12):1761-3
references.pmid: 11843256
references.citation: Cancer Invest. 2002;20(1):3-10
references.pmid: 11853000
references.citation: Am J Clin Oncol. 2002 Dec;25(6):599-602
references.pmid: 12478008
references.citation: Cancer Chemother Pharmacol. 1999;44(4):303-6
references.pmid: 10447577
references.citation: Arch Dermatol. 1995 Feb;131(2):202-6
references.pmid: 7857119
references.citation: Clin Colorectal Cancer. 2006 Sep;6(3):219-23
references.pmid: 17026792
references.citation: J Dermatol. 2004 May;31(5):403-6
references.pmid: 15187308
references.citation: Dermatologica. 1974;148(2):90-2
references.pmid: 4276191
references.citation: Breast. 2006 Jun;15(3):414-24
references.pmid: 16188440
references.citation: Clin J Oncol Nurs. 2005 Feb;9(1):103-6
references.pmid: 15751504
references.citation: Br J Cancer. 2003 Oct 6;89(7):1180-4
references.pmid: 14520442
references.citation: Br J Dermatol. 2000 Apr;142(4):808-11
references.pmid: 10792238
references.citation: Clin Breast Cancer. 2006 Jun;7(2):141-5
references.pmid: 16800973
references.citation: Cancer. 1995 Apr 15;75(8):2169-73
references.pmid: 7697608
references.citation: J Natl Cancer Inst. 1994 Apr 6;86(7):557-8
references.pmid: 7907667
references.citation: Br J Dermatol. 2000 May;142(5):1069-70
references.pmid: 10809894
references.citation: J Clin Oncol. 2006 May 1;24(13):e18-9
references.pmid: 16648492
references.citation: Oncology (Williston Park). 2004 Aug;18(9):1161-8, 1173; discussion 1173-6, 1181-4
references.pmid: 15471200
references.citation: Clin Cancer Res. 1998 Jun;4(6):1567-71
references.pmid: 9626479
references.citation: Pharmacotherapy. 2000 Oct;20(10):1221-3
references.pmid: 11034047
references.citation: Ann Intern Med. 1983 May;98(5 Pt 1):675
references.pmid: 6846998
references.citation: J Cutan Pathol. 1999 Jul;26(6):287-94
references.pmid: 10472757
references.citation: J Natl Cancer Inst. 1993 Sep 1;85(17):1432-3
references.pmid: 8102408
references.citation: Dermatol Online J. 2003 Feb;9(1):14
references.pmid: 12639472
references.citation: J Oncol Pharm Pract. 2006 Sep;12(3):131-41
references.pmid: 17022868
references.citation: Cancer Invest. 2006 Aug-Sep;24(5):514-6
references.pmid: 16939960
references.citation: Cancer Chemother Pharmacol. 1994;34(2):181
references.pmid: 8194170
references.citation: Ann Oncol. 2004 Mar;15(3):440-9
references.pmid: 14998846
references.citation: Oncology (Williston Park). 2002 Dec;16(12 Suppl No 14):31-7
references.pmid: 12520638
references.citation: J Clin Oncol. 2005 Jul 1;23(19):4424-9
references.pmid: 15994152